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The human gene TM7SF2 encodes a polypeptide (SR-1) with high sequence similarity to sterol C-14 reductase, 
a key sterol biosynthetic enzyme in fungi, plants and mammals. In Neurospora and y ast this enzyme is encoded 
by the erg-3 and erg24 genes respectively. In an effort to demonstrate sterol C-14 reductase activity for SR-1 we 
constructed six recombinant genes coding for chimeras of the Neurospora erg-3 and SR-1 protein sequences and 
tested them for complementation of the Neurospora rg-3 mutant. To our surprise, all the chimeras failed to 
complement erg-3. A few of the chimeric proteins were also tested against the yeast erg24 mut n , but again 
there was no complementation. We discuss some reasons that might account for these unexpected findings. 
[Prakash A and Kasbekar D P 2002 Genes encoding chimeras of Neurospora crassa erg-3 and human TM7SF2 proteins fail to complement 
Neurospora and yeast sterol C-14 reductase mutants; J . Biosci. 27 105–112] 
 
1. Introduction 
The human TM7SF2 gene was identified in cytogenetic 
region 11q13 based on the high amino acid sequence 
similarity (58% identity) of the 418 residue protein SR-1 
encoded by it, with the carboxyl terminal domain (CTD) 
of a 615 residue protein, the lamin B receptor (LBR), 
encoded by a different gene in 1q42×1 (Holmer et al 
1998). The SR-1 protein is localized to the endoplasmic 
reticulum whereas LBR is in the inner nuclear membrane 
of interphase cells. LBR mediates the mitosis-related dis-
assembly and reassembly of the nuclear envelope (for a 
review on LBR see Kasbekar 1999). The amino terminal 
~ 200 residues of LBR are hydrophilic whereas the ~ 400 
residue CTD is hydrophobic and contains putative mem-
brane spanning segments. The LBR CTD possesses sterol 
biosynthetic activity. Specifically, it can function as a 
sterol C-14 reductase (Silve et al 1998; Prakash  
et al 1999). The sterol C-14 reductase activity of the  
LBR CTD explained its unexpected high sequence 
similarity with fungal sterol C-14 reductases (Papa-
vinasasundaram and Kasbekar 1994; Schuleret al  
1994; Ye and Worman 1994; D P Kasbekar, unpublished 
results). Of the 12 exons of the LBR gene, the first  
four code for the hydrophilic amino terminal domain and 
the remaining eight code for the sterol reductase domain. 
A large (~ 10 kb) intron separates the fourth and fifth 
exons (the next largest intron is 4 kb), which suggested 
that the LBR gene most probably evolved by a recom-
bination between two primordial genes, one that encoded 
a basic nuclear protein and the other a sterol C-14 
r ductase. The splicing pattern of the TM7SF2 trans- 
cript is conserved relative to that of the eight exons 
encoding the LBR CTD, which suggests that SR-1 is 
a paralogue of the LBR CTD (Holmer et al 1998).  
The human SR-1 protein shares 40% amino acid 
sequence similarity with the sterol C-14 reductase 
encoded by the N urospora crassa erg-3 ene (figure 1). 
Thus it was conceivable that SR-1 also is a sterol C-14 
r ductase. 
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 We wanted to test whether SR-1, like the LBR CTD, 
was capable of complementing fungal sterol C-14 
reductase mutants (Prakash et al 1999). In N. crassa 
sterol C-14 reductase is encoded by the erg-3 gene 
located in distal linkage group III (Grindle 1973, 1974; 
Perkins et al 1982). The cloning of erg-3 and deter- 
mination of its nucleotide sequence was described by 
Papavinasasundaram and Kasbekar (1993, 1994). Mutants 
in erg-3 are blocked in ergosterol biosynthesis and 
accumulate precursor sterols that remain unsaturated  
in the D14,15 bond (Ellis et al 1991; Prakash et al  
1999). Ergosterol has UV absorption maxima at 272, 282 
and 293 nm whereas the erg-3 mutant sterols absorb 
maximally around 250 nm. Two additional pheno- 
types discovered for erg-3 mutants were an increased 
sensitivity to isoflavonoid compounds (such as pisa- 
tin and biochanin A) and an increased resistance  
to the tomato saponin a-tomatine (Sengupta et al  
1995). In the yeast Saccharomyces cerevisiae, st rol  
C-14 reductase is encoded by the ERG24 gene and  
erg2 null mutants are not viable on rich medium  
but they are viable on synthetic medium (Crowley  
et al 1996). Both the Neurospora and the yeast mutants 
have been used previously to test for sterol C-14 
reductase function of proteins encoded by hetero- 
logous and engineered genes (Aparna et al 1998; Silve  
et al 1998; Prakash et al 1999; Prakash and Kasbekar 
2001). This paper reports the construction of recombi- 
nant genes encoding chimeras of human SR-1 and 
Neurospora erg-3 proteins and tests of their ability to 
complement the Neurospora erg-3 and yeast erg24 
mut nts. 
 
 
Figure 1. Alignment of the Neurospora sterol C-14 reductase (Ncerg 3) and SR-1 amino acid sequences. Identical residues at the 
same position in the two proteins are indicated. “+” represents conservative replacements. “–” i dicates a gap in the alignment. 
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2. Materials and methods 
2.1 Strains and plasmids 
The wild type N. crassa strain 74-OR23-1 mat A (FGSC 
No. 987) and the erg-3 mat a strain (FGSC No. 2725) 
were obtained from the Fungal Genetics Stock Center 
(FGSC), University of Kansas Medical Center, Kansas 
City, KS 66103, USA. The yeast erg24 mutant strain 
(AP2) was a gift from Dr Martin Bard (Indiana 
University-Purdue University, Indianapolis, USA). The 
wild type yeast strain BY5741 and the TM7SF2 cDNA 
clone RG48276 (henceforth referred to as pTM7), 
were purchased from Research Genetics, Huntsville 
(USA). The plasmid pAB448 was a gift from Dr Anand 
Bacchawat (IMTECH, Chandigarh). The plasmid pCSN44 
contains the hygromycin resistance gene, a selectable 
marker in Neurospora transformations (Stabenet al 
1989). Plasmid pKGP86 contains the cloned Neurospora 
erg-3 gene and has been described by Papavinasa-
sundaram and Kasbekar (1994). pKGP86 was double-
digested with SmaI and SspI and self-ligated to generate 
pSAC86 which eliminated the SacI site present in the 
Multiple Cloning Site (MCS). Plasmid pBH86 contains a 
modified version of the erg-3 gene in which the intronic 
HindIII site was destroyed (Prakash et al 1999). 
pMOD86 contains the erg-3 gene of Neurospora in which 
a PstI site in the 3¢ non-coding of erg-3 of the gene has 
been removed (Prakash et al 1999). The plasmids pCH1 
and pCH1-Hph encoding chimeras of human LBR CTD 
and Neurospora erg-3 proteins have been described by 
Prakash et al (1999). 
2.2 Growth and transformation conditions 
The Neurospora strains were cultured as described by 
Davis and De Serres (1970), and their phenotype was 
scored by streaking macroconidia onto 1×5% agar plates 
containing Vogel’s N medium plus FGS (0×05% fructose, 
0×05% glucose and 2% sorbose) and supplemented with 
appropriate antibiotics. The antibiotics tested were a-
tomatine (Sigma) at 90 mg ml–1 made from a 25mg ml–1 
stock solution in dimethyl formamide, biochanin A 
(Sigma) made from a 20 mg ml–1 stock solution in dimethyl 
sulphoxide and hygromycin B (Sigma) 200 mg ml–1 made 
from an aqueous stock solution. After an overnight 
incubation at 30°C, growth could be observed of only the 
wild type on biochanin A, and of only the erg-3 mutant 
on tomatine (Sengupta et l 1995). Only strains express-
ing the hph gene could grow on hygromycin. The presence 
of the transgene was confirmed by PCR using a gene-
specific primer and a vector-specific primer. 
 Conidia of the rg-3 mat a mutant strain were 
transformed as described previously (Prakash et al 1999) 
or by electroporation by the method of Turner et al 
(1997) and transformants were selected on Vogel’s-FGS 
medium supplemented with 200 mg hygromycin ml–1. 
Yeast strains were transformed by the LiAc/ssDNA/PEG 
method (Gietz et al 1992) and the transformants were 
selected on synthetic complete medium lacking uracil. 
The transformants were checked for growth on YPD 
medium and their sterols were analysed by UV spectro-
photometry. Sterols were isolated and analysed as 
described for Neurosp ra. 
2.3 Sterol analysis 
Mycelia were grown in liquid Vogel’s medium with 
glucose, harvested by vacuum filtration, lyophilized and 
ground with glass beads. The powdered mycelia were 
homogenized with water. Chloroform was added to the 
homogenate (4ml per 1×6 ml homogenate), the mixture 
was vortexed and then 2 ml of 0×9% (w/v) aqueous KCl 
was added and vortexed. The aqueous and organic phases 
were separated by centrifugation and the bottom organic 
phase was collected in a fresh tube and washed twice 
with 2 ml 0×9% aqueous KCl. The chloroform was 
evaporated in a rotary evaporator and the residue of non-
saponified lipids was dissolved in hexane. This sample 
was diluted 1: 200 in ethanol and its UV absorption 
spectrum (200–3 0 nm) was recorded in a Hitachi spectro-
photometer. 
2.4 Construction of genes encoding chimeras of 
N. crassa erg-3 and SR-1 proteins 
Six recombinant genes (CH4, CH5, CH6, CH7, CH8 and 
CH9) were constructed that encode chimeras of erg-3 and 
SR-1 protein sequences. Figure 2 schematically repre-
sents the segments of the erg-3 protein that were replaced 
by corresponding segments of SR-1. In CH4 the first 290 
amino acid residues of erg-3 are replaced with the first 
250 residues of SR-1, in CH5 291-478 of erg-3 is 
r placed with 251-406 of SR-1. CH6 is almost entirely 
derived from SR-1 except for the last 12 residues, which 
are from erg-3. In CH7, CH8 and CH9 erg-3 segments 
213–290, 244–290 and 213–243, are replaced by SR-1 
segments 178–250, 204–250 and 178–204 respectively. 
 To construct CH4 we took advantage of two NcoI sites 
conserved between pTM7 and pCH1, a previously cons-
tructed recombinant gene which encodes a chimera of 
erg-3 and LBR (Prakash et al 1999). The first site is 
locat d at the start codons of erg-3 (nt. 387) and SR-1 
(nt. 125) and the second site is in the SR-1 ORF (nt. 866) 
and in the corresponding segment that was derived from 
LBR. The 741 bp NcoI fragment from pTM7 was ligated 
with the complementary NcoI fragment of pCH1.  
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Plasmids with correctly oriented inserts were identified 
on the basis of the asymmetrically located PstI site (see 
figure 3). The 1×135 kb KpnI/EcoRV fragment of the 
resulting plasmid, designated as pCH4, was ligated with 
pCH1-Hph digested with thesame enzymes to produce 
pCH4-Hph. 
 To construct CH5 we took advantage of a conserved 
EcoRV site in the rg-3 gene (nt. 1342) and in the 
corresponding position of pTM7 (nt. 873). Using oligo-
nucleotide primers P1 5¢TCACCACCATGGATATCAC- 
ACT3¢ and P2 5¢AGGCACAAGCTTGCAGTACTCCT3¢ 
we performed a PCR to amplify a 496 bp fragment (nt. 
No 861–1356) of pTM7 and also create a HindIII site at 
position 1341, to correspond to one in erg-3 at position 
1910. Cloning of the amplified fragment into pBSK 
produced the plasmid pRVH. The 473 bp EcoRV/HindIII 
fragment of pRVH was ligated with EcoRV/HindIII 
digested pBH86 (in which the HindIII site in the rg-3 
intron is destroyed). The 1×2 kb KpnI/EcoRV fragment 
from pCH4 was ligated with pCH5 digested with the 
same enzymes resulting in the construction of pCH6. 
 A single base deletion (of nt. 909 of TM7SF2 cDNA) 
that was not present in the original pTM7 template was 
detected upon sequencing pRVH. We removed this 
mutation from pCH6 by replacing the affected EcoRI 
fragment with the corresponding fragment from pTM7. 
The “corrected” plasmid, called pCH’6, was verified by 
sequencing. The 1×8 kb KpnI/BamHI fragment from 
pCH’6 was partially filled-in with Klenow was ligated 
with pCSN44, prepared by double digesting with KpnI/ 
XhoI and partial filling-in with Klenow. The r sulting 
plasmid was designated pCH’6-Hph. The 1×3 kb KpnI/ 
EcoRV fragment from pKGP86 was ligated with pCH’6 
double digested with the same enzymes to generate the 
“corrected” plasmid pCH’5. A 2×4 kb XhoI/EcoRV frag-
ment from pCSN44, which carries the hph gene was 
pa tially filled-in with Klenow and ligated with pCH’5, 
prepared by double-digesting with BamHI/SspI and 
partially filling-in with Klenow to produce pCH’5-Hph. 
 Construction of CH7 used the SacI and EcoRV sites at 
positions 1116 and 1342 of erg-3 which are also conser-
ved in TM7SF2 (figure 3). Plasmid pKGP86 was double-
digested with SmaI/SspI and self-ligated to produce 
pSAC86. The SacI/EcoRV fragment of pTM7 was ligated 
into pSAC86 digested with the same enzymes and resul-
ted in the production of pCH7. 
 
2.5 Site-directed mutations 
The mutations G225C, Y317F and E475Q were intro-
duced into the cloned erg-3 gene by site-directed muta-
genesis using the protocol described in the BIORAD 
catalogue (No. 170-3576). Oligonucleotides with the 
desired mismatch were used to prime synthesis of the 
complementary strand of single- tranded pMOD86 DNA. 
The presence of the engineered mutation and absence of 
any artefactual mutations was verified by sequencing. 
The appropriate alignments were carried out using the 
CLUSTAL W program with ten sterol C-14 reductase 
 
Figure 2. Schematic representation of chimeric proteins CH4-CH9. Segments derived 
from Neurospora erg-3 and from SR-1 are represented, respectively, by open and filled 
bars. N, NcoI; E, Eco0109I; H, HindIII; P, PstI; RV, EcoRV; S, SacI. 
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sequences. This multi-alignment has been used effec-
tively by us in other work to identify residues in the erg-3 
protein that are essential for its sterol C-14 reductase 
activity (Prakash and Kasbekar 2001). 
 An Eco0109I site is present between the SacI and 
EcoRV sites of pTM7 (figure 2). Site-directed mutagenesis 
with the oligonucleotide primer E1-5¢CAGTTCAGA- 
AGGACCCAGCCCAGA3¢ and single-stranded pMOD86 
DNA was used to create a corresponding Eco0109I site in
erg-3. The resulting plasmid was designated pEC86. 
2.6 Construction of pCH8- ph and pCH9-Hph 
Digesting pCH7 and pEC86 with Eco0109I and SmaI 
released fragments of sizes 822 and 840 bp respectively. 
By switching the fragments/vector pairs, followed by 
ligation, we produced pCH8 and pCH9. pEC86, pCH8 
and pCH9 were digested with KpnI/EcoRV and the 
released ~ 1×3 kb fragments were ligated with pCH1-Hph 
digested with KpnI/EcoRV resulting in the formation  
of plasmids pEC86-Hph, pCH8-Hph and pCH9-Hph 
respectively. 
2.7 Construction of vectors for expression 
of chimeras in yeast 
PCR primers 5¢AGCGGAGACCATGGCCCCCACTC3¢ 
and 5¢TGTTCATCCTCAGTAGATGTA3¢ were used to 
amplify the SR-1 ORF using the high fidelity Pfu DNA 
polymerase and pTM7 as the template. The amplified 
fragment was cloned into the EcoRV site of pBSK. The 
orientation of the PCR product was tested by digestion 
with SacII. Plasmids pTM1 and pTM2 which released a 
1×2 kb fragment on digestion with SacII were sequenced 
using vector primers to confirm the absence of artefactual 
mutations. The SmaI/HindIII fragment from pTM1 was 
inserted into pAB448, a multicopy yeast expression 
vector containing a strong TEF promoter, CYC1 termi-
nator and a selectable URA3 marker (Mumberg et al 
1995). The resulting plasmid was designated as pABTM7. 
 The 1×6 kb AccI/SpeI fragment from pCH4 was par-
tially filled (2 base fill-in) using Klenow and ligated with 
pAB448, which was double digested with SmaI/HindIII 
and subsequently, partially filled-in (2 base fill- n) with 
Klenow. The resulting plasmid was named pABCH4. 
 Plasmid pABERG3 contains the coding sequence  
of the Neurospora erg-3 gene in pAB448. The 1×3kb 
HindIII fragment excised from pCH7 was ligated with 
pABERG3 digested with the same enzyme. Plasmids 
with inserts in the correct orientation were identified  
by digestion with BamHI, whose site is asymmetrically 
located. This resulted in the formation of pABCH7. 
 
3. Results 
3.1 Complementation tests in Neurospora 
The constructs pCH4- ph, pCH’5-Hph, pCH’6-Hph 
were introduced by electroporation into erg-3 mutant 
conidia. Plasmids pCH7 and pSAC86 were introduced by 
co-transformation with the plasmid pCSN44 which 
carries the hph gene. Transformants were selected on 
hygromycin-medium. Hygromycin-resistant transformants 
were tested for growth on biochanin A. The UV-spectrum 
of the sterols from the transformants was also recorded. 
As expected, the plasmid pSAC86 could complement the 
erg-3 mutant phenotype. However, the transformants 
obtained with pCH4- ph, pCH’5-Hph, pCH’6-Hph and 
pCH7 were all biochanin A sensitive. The transformants 
also lacked any trace of ergosterol as determined by UV 
s ectroscopy of the isolated sterols (figure 4). These 
results indicated that the four chimeric proteins did not 
possess sterol C-14 reductase activity. 
 We attempted to pinpoint the region responsible for 
non-complementation in the plasmid pCH7 by construct-
ing smaller chimeric proteins that together spanned this 
region (figure 2). Plasmids pEC86-Hph, pCH8-Hph and 
pCH9-Hph were used to transform the erg-3 mutant by 
electroporation. The hygromycin-resistant transformants 
were tested for the presence of ergosterol. pEC86 com-
plemented the erg-3 mutant phenotype indicating that the 
c eation of the Eco0109I site does not affect the comple-
menting ability of the erg-3 gene. However both pCH8-
 
Figure 3. Restriction sites in the Neurospora erg-3 gene and in the TM7SF2 cDNA. 
A, AccI; B, BamHI; E, Eco0109I; H, HindIII; N, NcoI; P, PstI; R1, EcoRI; RV, EcoRV; 
S, SacI. The start and stop codon positions are indicated.
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Hph and pCH9-Hph did not complement the mutation 
(data not shown). 
3.2 Testing for complementation by the 
site-specific mutations 
Residues G225, Y317 and E475 of Neurospora erg-3 are 
conserved in most sterol C-14 reductases but they are 
replaced by cysteine, phenylalanine and asparagine, 
respectively, in SR-1. To test whether these differences 
might affect sterol C-14 reductase activity in Neurospora 
we engineered these changes into the Neurospora rg-3 
sequence. Plasmids bearing e g-3 genes with the muta-
tions G225C, Y317F and E475Q were co-transformed 
with pCSN44 into erg-3 mutant conidia. The hygromycin 
resistant transformants were tested for growth on bio-
chanin A and for their ability to synthesize ergosterol. All 
three mutants were able to complement the erg-3 mutant 
phenotype thereby indicating that the lack of sterol C-14 
reductase activity cannot be attributed to the differences 
at these positions (data not shown). 
3.3 Complementation tests in yeast 
Expression of foreign enes in Neurospora may be 
affected by methylation and quelling (Pandit and Russo 
1992). Such phenomena have not been observed in yeast. 
Moreover, at least in some cases yeast provides a more 
sensitive assay system for sterol C-14 reductase than 
Neurospora; two engineered genes that did not show  
any complementation in Neurospora could nevertheless 
weakly complement the yeast erg24 mutant (Prakash and 
Kasbekar 2001). Therefore we tested the chimeric const-
ructs for complementation in yeast. Yeast erg24 null 
mutants are not viable on rich medium but they are viable 
on synthetic medium (Crowley et al 1996). Plasmids 
pABTM7, pABCH4 and pABCH7 were transformed into 
the yeast erg24 mutant strain AP2. Control transforma-
tions were done with plasmids pABERG3 and pAB448. 
Transformants were selected on synthetic complete 
medium lacking uracil, streak purified and tested for 
growth on YPD medium. The sterols were also isolated 
from the transformants and their UV spectrum was 
recorded. Transformants obtained with pABERG3 were 
able to grow on YPD medium and could synthesize ergo-
sterol, indicating that the Neurospora erg-3 comple-
mented the yeast erg24 mutation. However pAB448, 
pABTM7, pABCH¢4 and pABCH7 did not show com-
plementation, indicating that the chimeric proteins are 
unable to support sterol C-14 reductase activity even in 
yeast (figure 5).
3.4 Tests for negative dominance 
We examined whether SR-1 or the chimeras might 
unction as negative dominant inhibitors of sterol C-14 
reductase by expressing them in the wild type yeast strain 
BY5741. Transformations were done with plasmids 
pAB448, pABERG3, pABTM7, pABCH4 and pABCH7 
and transformants were selected on synthetic medium 
lacking uracil. The transformants were streak purified 
and tested for growth on YPD medium and their sterols 
were analysed by UV spectroscopy. All the transformants 
were indistinguishable on YPD medium. Additionally, 
the UV spectrum indicated the presence of ergosterol and 
the absence of any intermediate sterols. Thus neither  
SR-1 nor the chimeric proteins displayed any dominant 
negative effect. 
4. Discussion 
Our studies revealed that SR-1 and the six chimeras 
containing SR-1 and Neurospora erg-3 protein sequences 
fail to complement sterol C-14 reductase mutants of 
Neurospora and yeast. We also did not find any evidence 
for negative dominant inhibition of sterol C-14 reductase 
by SR-1 in yeast. The uniform absence of complementation 
or negative dominance is unlikely to be because of non-
expression of the various transgene constructs because 
complementation could be demonstrated using constructs 
coding for the Neurospora erg-3 protein and also by the 
three site-directed mutant erg-3 alleles. Many constructs 
that failed to complement were in identical vector back-
grounds as those that showed complementation. Note that 
the 418 residue protein encoded by CH’6 is practically 
identical to SR-1; the first 406 residues are from SR-1 
and only the N-terminal 12 residues are from erg-3, of 
which six are identical between SR-1 and erg-3 and three 
are similar (see figure 1). CH’6 did not complement in 
 
 
Figure 4. Representative UV spectra of sterols from 
transformants of the N. crassa erg-3 strain. Note that ergosterol 
is synthesized by the transformant with pSAC86 (5) but not by 
transformants with pCH4-Hph (1), pCH5-Hph (2), pCH6-Hph 
(3) and pCH7 (4). 
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Neurospora and yeast, in contrast, the analogous construct 
CH3 could complement. CH3 encodes a protein, wherein 
all but the N-terminal 12 residues were from the human 
LBR CTD (a paralogue of SR1) and the terminal 12 were 
from erg-3 (Prakash et al 1999). Our sterol C-14 reduc-
tase complementation assay is efficient and has been used 
previously to confirm the functionality of erg-3 homo-
logues from Nectria haematococca, Septoria lycopersici, 
Ascobolus immersus and of the human LBR CTD. Addi-
tionally it has been used to ientify residues essential for 
enzyme activity (Prakash and Kasbekar 2001). 
 We had hoped to confirm the hypothesis that SR-1 is a
sterol C-14 reductase. But our inability to demonstrate 
complementation does not allow us to infer that SR-1 is 
not a sterol C-14 reductase. Therefore we need to 
consider how two human sterol C-14 reductases, SR-1 
and the LBR CTD, might have come to differ in their 
ability to function in fungi. One possibility is that the 
differences between SR-1 and the LBR CTD may be due 
to differences in their GC contents. GC rich sequences 
are inefficiently translated in yeast. The average GC 
content of the TM7SF2 sequence is 65%, and it is as high 
as 74% in the first 300 bp. The GC content of human 
LBR is around 54% and that of even a GC rich sequence 
in yeast is 44%. Additionally, the codon bias in TM7SF2 
appears to be different from the codon usage in yeast. 
The less preferred codons for many of the residues in 
yeast are the most frequent in TM7SF2. The effect of 
such a bias for hydrophobic residues like leucine, valine, 
isoleucine and phenylalanine will be severe a  they are in 
high proportion in a membrane protein. The pattern of 
codo usage for human LBR is not as drastically diffe-
rent from the preferred one in yeast. Batard et l (2000) 
encountered a similar problem in trying to express a 
wheat P450 cDNA in yeast. They found that the wheat 
cDNAs were efficiently transcribed, but found no protein 
or enzyme activity upon expression in yeast. Wheat 
coding sequences are characterized by a high GC content 
and by a related strong bias of codon usage different 
from that in yeast. The investigators re-engineered the 5¢-
end using a single PCR megaprimer designed to comply 
with the host’s codon usage and found that it relieved 
translation inhibition and resulted in greater protein 
expression. 
 However, if the high GC content of the TM7SF2 
cDNA was the responsible factor, then we might have 
expected at least the constructs with shorter stretches of 
the TM7SF2 cDNA to show complementation. Our nega-
tive finding might also reflect problems with the chimeric 
approach. Chimeras can potentially disrupt species-
spec fic intra-protein interactions. Interactions that may 
be fortuitously conserved between LBR CTD and the 
erg-3 protein could be disrupted in the chimeras with  
SR-1. The hypothesis that intraprotein interactions might 
be disrupted in the chimeras can be tested by isolating 
revertants that are able to grow in rich medium. Unfortu-
nately, we were unsuccessful in our attempts to isolate 
“revertants” on rich medium. It is possible that the  
 
 
Figure 5. Growth on rich medium of the yeast erg24 mutant strain AP2, and transformants of AP2 with pABERG3, pABTM7, 
pABCH4 and pABCH7. Note that only the transformant with pABERG3 is able to grow on rich medium.
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“chimera effect” affected the constructs containing shorter 
stretches of SR-1 whereas the GC content and codon bias 
could have contributed to the lack of complementation by 
the recombinants with longer stretches of SR-1. 
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